miR‐223‐3p promotes autoreactive Th17 cell responses in experimental autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression

0301 basic medicine Biochemistry & Molecular Biology Physiology Medical Physiology Inbred C57BL Autoimmune Disease Autoimmune Diseases Uveitis Mice 03 medical and health sciences IL-23 Medical physiology Receptors IL-22 2.1 Biological and endogenous factors Animals Aetiology Eye Disease and Disorders of Vision Biomedical and Clinical Sciences Animal Forkhead Box Protein O3 pathogenic Th17 cells GM-CSF Receptors, Interleukin Biological Sciences Interleukin Up-Regulation Mice, Inbred C57BL Disease Models, Animal MicroRNAs Gene Expression Regulation Biochemistry and cell biology Disease Models Th17 Cells Female Biochemistry and Cell Biology IL-23R Biotechnology Signal Transduction
DOI: 10.1096/fj.201901446r Publication Date: 2019-10-24T01:35:41Z
ABSTRACT
Pathogenic T helper (Th)17 cells are key mediators of autoimmune diseases such as uveitis and its animal model, experimental autoimmune uveitis (EAU). However, the contribution of microRNAs (miRs) to the intrinsic control of pathogenic Th17 cells in EAU remains largely unknown. Here, we have reported that miR‐223‐3p was significantly up‐regulated in interphotoreceptor retinoid‐binding protein‐specific Th17 cells, and its expression was enhanced by IL‐23‐signal transducer and activator of transcription 3 signaling. Knockdown of miR‐223‐3p decreased the pathogenicity of Th17 cells in a T‐cell transfer model of EAU. Mechanistic studies showed that miR‐223‐3p directly repressed the expression of forkhead box O3 (FOXO3), and FOXO3 negatively regulated pathogenic Th17 cell responses partially via suppression of IL‐23 receptor expression. Thus, our results reveal an important role for miR‐223‐3p in autoreactive Th17 cell responses and suggest a potential therapeutic avenue for uveitis.—Wei, Y., Chen, S., Sun, D., Li, X., Wei, R., Li, X., Nian, H. miR‐223‐3p promotes autoreactive Th17 cell responses in experimental autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression. FASEB J. 33, 13951‐13965 (2019). www.fasebj.org
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (69)
CITATIONS (32)